Vildagliptin
Therapeutic Group
Blood Glucose Lowering Drugs, Excluding InsulinIndication Dosage
Type 2 Diabetes Mellitus As Monotherapy Or In Combination With Metformin Or Pioglitazone (dual Therapy) Or In Combination With Both Metformin And A Sulfonylurea (triple Therapy) Or In Combination With Insulin (with Or Without Metformin) To Achieve Adequate Glycaemic Control:
- Adult: 50 Mg Twice Daily
Type 2 Diabetes Mellitus In Combination With Sulfonylurea (if Metformin Inappropriate):
- Adult: 50 Mg Daily, Dose To Be Taken In The Morning Dose Of Concomitant Sulfonylurea Or Insulin May Need To Be Reduced.
- Children: Not Recommended.
Content
- Tab 50mg: Vildagliptin 50mg.
Pregnancy
Contraindicated In Pregnancy.
Stability
- Dipeptidyl Peptidase-4 Inhibitor
Contra Indications
- Ketoacidosis, Severe Heart Failure, Severe Hepatic Impairment.
Precautions
- Ketoacidosis, Severe Heart Failure, Severe Hepatic Impairment.
Lactation
- Contraindicated or Not Recommended.
Side Effects
- Peripheraloedema
- Lactic Acidosis (discontinue)
- Asthenia
- Dizziness
- Headache
- Tremor
- Arthralgia
- Constipation
- Hypoglycaemia
- Rare: Hepatic Dysfunction
- Upper Respiratory Tract Infection
- Nasopharyngitis
- Exfoliativeskin Reactions And Pancreatitis (discontinue).